Corteva (CTVA) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Corteva is expected to report Q3 2026 results after market close Wednesday, November 11. Analysts forecast earnings of $0.0181 per share and revenue of $1.77 billion; the conference call is scheduled for November 12 at 9:00 a.m. ET.
• The company cut its quarterly dividend to $0.05 per share from $0.18, equivalent to $0.20 annually and a stated 1.7% yield.
• Analyst sentiment is broadly positive: 16 analysts rate the stock Buy, six Hold, and one Sell, giving it a consensus “Moderate Buy” rating and an average price target of $60.59.

Corteva (NYSE:CTVA - Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Wednesday, November 11th. Analysts expect Corteva to announce earnings of $0.0181 per share and revenue of $1.77 billion for the quarter. Individuals can find conference call details on the company's upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 12, 2026 at 9:00 AM ET.

Corteva Stock Down 0.3%

Shares of NYSE CTVA opened at $11.88 on Wednesday. The firm has a market capitalization of $7.93 billion, a PE ratio of 7.87, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a 1 year low of $11.24 and a 1 year high of $90.97. The firm's 50-day moving average is $49.07 and its 200-day moving average is $71.96.

Corteva Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 1.7%. This is a negative change from Corteva's previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Tuesday, December 1st. Corteva's payout ratio is presently 47.68%.

Analyst Upgrades and Downgrades

CTVA has been the topic of several analyst reports. BMO Capital Markets set a $15.00 price objective on shares of Corteva in a report on Friday, October 2nd. New Street Research set a $17.00 target price on shares of Corteva in a report on Monday, October 5th. The Goldman Sachs Group reiterated a "buy" rating and set a $20.00 target price on shares of Corteva in a research report on Thursday, October 8th. Mizuho upped their target price on shares of Corteva from $96.00 to $97.00 and gave the company an "outperform" rating in a research report on Tuesday, July 14th. Finally, Zacks Research downgraded Corteva from a "hold" rating to a "strong sell" rating in a research note on Tuesday, October 6th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $60.59.

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an agriculture company that develops and supplies products and services designed to help farmers improve crop productivity, protect yields and manage agricultural challenges. Its business is organized primarily around seed and crop protection products.

The company's seed portfolio includes branded corn, soybean, cotton, sunflower, canola and other crop varieties, supported by plant genetics and biotechnology. Its crop protection business offers herbicides, insecticides, fungicides and seed-applied treatments, along with biological and digital agriculture solutions intended to support crop health and farm-management decisions.

Corteva was formed through the separation of the agriculture division of DowDuPont and became an independent public company in 2019.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.